STADA names new UK general manager

Pharmaceutical manufacturer STADA has appointed Craig Shaw as its new UK general manager, bringing more than 25 years of senior experience across the health and personal care sectors. 

Craig previously held leadership roles at Scholl’s Wellness Company, Reckitt Benckiser and Novartis Consumer Healthcare, most recently serving as chief executive of Scholl, where he led its transition into a fully independent global business.

In his new role, Craig will support growth across STADA’s three strategic pillars – consumer healthcare, generics and specialty – helping to advance brands such as Nizoral, Cetraben, Covonia, Savlon, Hedrin and Zoflora.

Craig said: “STADA’s agility and consistent outperformance within the industry have long impressed me. 

“I’m excited to join the team and unlock the full potential of our established brands including Nizoral®, Zoflora®, Cetraben®, Covonia®, Hedrin®, and Savlon®.

“At the same time, we will continue to build momentum in our specialty portfolio.

“There’s a talented and entrepreneurial team here, and we’re going to reenergise to really leverage our diverse brand portfolio. 

“I’m looking forward to driving STADA UK to reach its next phase of growth, and we’ll do that by supporting customers, healthcare professionals, suppliers and across the UK with great products and treatments they need.”

The UK is one of STADA’s top five markets, representing around seven per cent of group revenues. 

Alongside its consumer brands, STADA UK supplies generic and specialty medicines and operates key manufacturing sites in Huddersfield and Preston, producing liquids, semi-solids, herbal medicines and supplements for both the UK and international markets.

Peter Goldschmidt, chief executive of STADA, added: “With the UK ranking among STADA’s five largest countries by revenues, accelerating UK growth organically and inorganically is a key strategic priority. 

“We are, under Craig’s experienced leadership, embarking on a new chapter of growth in the UK, including by actively seeking attractive acquisition opportunities to strengthen our portfolio and pipeline of consumer healthcare, generics and specialty products.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →